chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Painful Left Thumb; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful Left Thumb) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Painful Left Thumb). The patient was treated with STEROIDS at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Painful Left Thumb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had a history of thumb problems. No concomitant medication information was provided.  .
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for 1 day, in left arm, as dose 2, single (Batch/Lot number: unknown) for 1 day, in left arm and on 27Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Occasional asthma" (unspecified if ongoing); "dairy" (unspecified if ongoing); "sulfa" (unspecified if ongoing); "history of pneumonia x2" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Fosamax, reaction(s): "Known allergies: Fosamax"; Erythromycin, reaction(s): "Known allergies: erythromycin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Indication: Covid-19 treatment; (13Jul2022) Positive, notes: + Covid 13Jul; (20Jul2022) Negative, notes: tested Negative 20Jul; (30Jul2022) Positive, notes: Tested Positive 30Jul. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Paxlovid, + Covid 13Jul, took 5 days Paxlovid 15Jul to 19Jul, tested Negative 20Jul. Covid symptoms returned 28Jul. Tested Positive 730. Cough, sinus congestion, sore throat, fatigue. Other medication in 2weeks: No. Dose 1 and dose 2 were administered on 19Feb2021.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
AFTER I LEFT THE VACCINE SITE ABOUT 5 MIN LATER MY FACE AND LIPS STARTED TO SWELL. THE LIP SWELING RESOLVED ABOUT 15 MINS AFTER ONSET AND THE FACIAL SWELLING ABOUT AN HOUR AFTER ONSET.
COVID-19 Vaccine EUA; A week after vaccination my  left arm developed a large rash just below the injection site,  about 7in x 4in. It is warm to the touch. It was sore the first day and is sometimes slightly itchy.  It has been 4 days and it appears to be resolving (it is not as red).
A report has been received from a Health Professional concerning a patient, Male subject, who had been receiving FLUMIST quadrivalent (intranasal) 0.2 milliliters, once/single. FLUMIST quadrivalent started on an unknown date. The reporter stated that the patient number seven was given FLUMIST that underwent a temperature excursion and it was unknown if the dose of 0.1ml was given in each nostril. The outcome of the event of patient number seven given FLUMIST that underwent a temperature excursion and it is unknown if the dose of 0.1ml was given in each nostril is unknown. The report was considered to be non-serious.
Patient was administered vaccine that was improperly stored (in freezer for too long and considered expired by manufacturer at date of administration due to lack of study data). Patient noted no adverse reactions and acknowledged recommendation for revaccination.
Sick in bed; Huge headache sore; Sore and achy; Tired; Nauseated; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix (first dose received on an unknown date).   On 1st August 2022, the patient received the 2nd dose of Shingles vaccine. In August 2022, less than a week after receiving Shingles vaccine, the patient experienced sickness, headache, pain, tiredness and nausea. On an unknown date, the outcome of the sickness, headache, pain, tiredness and nausea were unknown.   It was unknown if the reporter considered the sickness, headache, pain, tiredness and nausea to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-AUG-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient received the second dose one day before reporting day. The patient experienced sick and he/she was in bed and patient was glad to get it. The patient was asking that did anyone had a huge headache, sore and achy and tried and nauseated. Follow-up would not possible, as no contact details were available.
This spontaneous report as received from a Certified Medical Assistant refers to a patient of unknown age and gender. On 20-APR-2015, the patient was vaccinated with one dose of PROQUAD (Merck) that had been improperly stored (subcutaneous, lot # K025760, expiry: 08-JUN-2016, dose not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information hs been requested.
Painful mouth ulcers began 2 weeks post 2nd vaccine. I have never experienced this before. Very painful.
pt c/o dizziness, h/a & muscle weakness about 15min p/vax;no rash, SOB, or other difficulties were noted;pt taken to nurse office  & observed & allowed to lie down;grandma picked child up & felt has same virus had 1wk ago;
Patient received the vaccine after expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine after expiry) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 038B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HCTCZ (Hydrochlorothiazide), ROSUVASTATIN and OMEPRAZOLE for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine after expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine after expiry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication not reported.  Treatment medication not reported.
Mom called 5/3/18 the next day after vaccines were given and states Patient right upper arm was swollen, warm, and itchy. Advised parent to give BENADRYL, Ibuprofen, and cold compress and told the area may get worse before it is better but should improve over the next 3-4 days. Advised to call back if symptoms are worsening or not improving with treatment advised. Mom called 5/5/18 and states patient is unable to move his arm and swelling is worse. Dr on call advised mom to take patient to the ER. ER diagnosed patient with post-immunization reaction T88.1xxa and allergic reaction T78.40xa. Today patient is doing well with some mild redness in the area.
I did not get my period for almost 7 months after I received my vaccine. I did though become pregnant 8 months after getting the vaccine.
typical soreness on arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (typical soreness on arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced MYALGIA (typical soreness on arm). At the time of the report, MYALGIA (typical soreness on arm) had resolved. Not provided.      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications reported.   Treatment information not reported.   This case was linked to MOD-2021-234576 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received and outcome of the event updated.
MUSCLE TWITCHING OF THE RIGHT ARM; BILATERAL LEG PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient not had any drug abuse / illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-APR-2021, the subject experienced muscle twitching of the right arm. On 12-APR-2021, the subject experienced bilateral leg pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from muscle twitching of the right arm, and bilateral leg pain on APR-2021. This report was non-serious.
Very strong period. Cramping similar to labor contractions. Period arrived 13 days before normal date.
Headache, fever and chills, muscle aches and fatigue  Took Tylenol to try and help with symptoms.
Fist night chills. Nights two and three fevers and night sweats. Days 4 nad 5 non-itchy 'hives' on both legs. Day 5 to 10 inflanmmation in joints, expecially, thumbs, knees ankles
Vaccine April 24th 9:15 am, by afternoon was feeling tingling and numbness in left side of face. April 25th, arm hurt, headache (typical), but tingling and numbness was increasing. It felt like I had a novocaine shot. April 25th Doctor said to got to ER. At ER they had me take an EKG, Full Blood Work, CT Scan and CTA Scan. MRI to be determined in a couple days.
This spontaneous report was received from a physician via company representatives and from a support services director concerning to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications was not reported. On 24-DEC-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 which had the lot # K009874 with expiration date 19-MAR-2016 (dosage number and route of administration were not reported). On an unspecified date, the vaccine had a temperature excursion for 24 hours in which the lowest recorded temperature was 34 degrees Fahrenheit (1.111111111 degrees Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported and no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
mild brain fog; she felt slight dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Aug2021 (Lot number: FC3181) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Psoriasis" (unspecified if ongoing), notes: Verbatim: Psoriasis, She has a skin condition, She was diagnosed with both 6 years ago.; "Sjogren's" (unspecified if ongoing), notes: Verbatim: Sjogren's,dry eyes, and dry mouth. She was diagnosed with both 6 years ago. Concomitant medication(s) included: DIGESTIVE ENZYMES; VITAMIN D; VITAMIN K. The following information was reported: FEELING ABNORMAL (non-serious) with onset 09Aug2021, outcome "not recovered", described as "mild brain fog"; DIZZINESS (non-serious) with onset 09Aug2021, outcome "unknown", described as "she felt slight dizziness".  No follow-up attempts are possible. No further information is expected.
No fever.  Entire thigh swelled from groin to knee.  Sx noted on 2/25/08.  Leg was red & swollen.  Pt was seen 2/27/08 - thigh diameter 25 cm.
Almost 3 days after vaccination patient presents signs of seizure with temperature of 37.6 Celsius, mother indicates child was with father when he called ambulance and that the child was cyanotic, drowsy and unresponsive.
Blurred eye vision, tight throat and chest, extreme fatigue, chest pain, numbness, headache, in and out of consciousnesses, heart racing, memory losses, 2 shots of EPI- Pens, ICU Hospital Stay. Ambulance was called and I was on oxygen when I came to at Hospital Benadryl and Pepcid, also administered. See medical records which I will send when Doctors have filed them and finished them. So much happened.
9/28/2021 Low grade fever 100.7 9/28/2021 Chills 9/30/2021 Low grade fever 100.6 9/30/2021 EMERGENCY ROOM  VISIT @00:36  Fever/bronchspastic cough, CT Scan showed pneumonia in both lungs
Patient has hx. of fainting from shots. Patient did not relay this information before getting shot. Patient stood up after shot and fainted. Patient became A&O x3 within 30 seconds of fainting. Patient hit face and knees on ground and sustained minor abrassions to left knee and over left eye. Patient assessment included EKG, vitals, glucose. All findings were appropriate. Patient states he feels good and declines to ED further assessment. Patient signed refusal of transport document.
Initial report received from a health care provider on 10/26/05. A seven year old male with a medical history of asthma received in the left deltoid an injection of Fluzone, lot number U1746AA on 9/19/05. Ten days later, the patient developed slurred speech and left sided mouth dropping. The patient was examined in an emergency room and diagnosed with Bell's Palsy. He was scheduled for an appointment with a neurology clinic, but was totally well by 10/14/05. The patient received a previous dose of Fluzone in December 2004. Other medications and illness at the time of vaccination were not reported. At the time of this report, the patient had recovered.
The patient was sitting on the bed and fell backwards and hit the back of her head. She started having a seizure for 5 minutes, head to the side, arms/hands twitching and passed out. After 5 min or so patient was conscious and started she felt dizzy, cold, right arm numb and complained of back pain.
pt recv vax & began getting gen urticaria 4 days later;still moderate urticaria on 6/25;also nasal stuffiness;treated w/DPH;mom has hx of chronic urticaria;
Information has been received from a physician concerning a female patient who was vaccinated with three 0.5ml doses of GARDASIL (lot#s not reported) respectively on 17-MAR-2009, 15-MAY-2009 and 30-DEC-2009.  On 22-FEB-2010 the patient experienced syncope and was rushed to the hospital by ambulance.  It was reported that the patient had had other syncope events since then.  Electroencephalography and cardiology test were performed with no results reported.  At the time of this report, the patient's outcome was not reported.  Additional information has been requested.
PATIENT HAD A SEIZURE FOR 2 TO 3 MINUTES THE EVENING OF HIS APPOINTMENT (HIS WIFE WITNESSED). HE HAS NO HISTORY OF SEIZURES. HE IS GETTING SEVERE HEADACHES STARTING FROM THE TIME HE HAD THE SEIZURE AND THEY HAVE CONTINUED FOR NOW ALMOST TWO WEEKS WITH NO IMPROVEMENT.
Fever as high as high as 100.8, chills, whole body muscle aches, arthritis inflammation, extreme sweating, headache all lasting up to 48 hours post vaccine
This spontaneous report as received from a nurse refers to a 18 year old patient of unknown gender. Medical history and concurrent conditions were not reported. On 04-MAY-2015, the patient was vaccinated with an improperly stored GARDASIL dose 3, lot # K005881, expiration date 14-JAN-2017 (dose and route were not reported). No adverse event reported. No co-suspect and concomitant therapies were reported. This is one of several reports from the same source. Additional information is not expected. All follow up requested to complete the case were received.
Initial case received from a nurse practitioner on 17 November 2009. This reporter also noted similar symptoms in another patient; the event is captured in case number 2009-05022. A five-year-old female patient received an injection of H1N1 (lot number UP019AA) on 11 November 2009, and twelve hours later experienced three episodes of vomiting and diarrhea. The patient had also experienced a similar episode five days prior to vaccination. Outcome was not reported. Follow-up information was received 22 February 2010 from a health care professional who reported that the patient had fully recovered (date not reported). The event did not require treatment or a doctor's visit. No additional information was provided. Documents held by sender: None.
patient called to clinic complaining of swelling redness and warmth to injection site. monitor for now treatment Tylenol and ice packs monitor for now. f/u in clinic in am
Information has been received from nurse concerning a patient of unknown age and gender. No known history condition and drug allergies. On 18-MAR-2015, the patient was vaccinated with MMR II (Oka/Merck) VARIVAX and VAQTA (dose, route, lot # and expiration date unknown). The reporter stated that after administering, some of the "vaccine dripped out of the injection site". No adverse effects reported. Additional information has been requested.
Quite difficult for her to walk; Right knee swelled up right after the shot; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Right knee swelled up right after the shot) and GAIT DISTURBANCE (Quite difficult for her to walk) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced JOINT SWELLING (Right knee swelled up right after the shot) and GAIT DISTURBANCE (Quite difficult for her to walk). At the time of the report, JOINT SWELLING (Right knee swelled up right after the shot) and GAIT DISTURBANCE (Quite difficult for her to walk) outcome was unknown.            Concomitant medication was not provided. Treatment information was not reported.   Reporter did not allow further contact
The shakes; weakness; chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (The shakes), ASTHENIA (weakness) and CHILLS (chills) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TREMOR (The shakes), ASTHENIA (weakness) and CHILLS (chills). At the time of the report, TREMOR (The shakes), ASTHENIA (weakness) and CHILLS (chills) had resolved.            No concomitant medication were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: NNI On 08-Jul-2021: Significant FU: AE outcome updated
Experienced rigor throughout the night after vaccination. Also experienced swelling, rash, pain and erythema at the injection site from day 2 thru day 10.
This case was reported by a healthcare professional via a sales representative and described the occurrence of hypersensitivity reaction in a female subject of unspecified age who was vaccinated with TWINRIX (GlaxoSmithKline).  There were no concurrent medications.  On 20 August 2008 the subject received 1st dose of TWINRIX at 0.5 ml in an unknown arm.  On the morning of 21 August 2008, 1 day after vaccination with TWINRIX, the subject experienced hypersensitivity reaction, arthritic-like symptoms all over the body, bloody nose and ear discharge.  There were no local reactions at the site of TWINRIX administration.  The reporter sent the subject to the emergency room.  It was reported that she was going to require treatment, but no details of the treatment were known at the time of reporting.  The healthcare professional considered the events were disabling.  At the time of reporting the events were unresolved.  The healthcare professional considered the events were probably related to vaccination with TWINRIX.
Terrible legs pain, including the area between hip and torso. Any movement makes it feel like it's being cut off the torso. The left leg is more painful (the vaccine was given in the left hand). Unbearable pain; Dr. prescribed a couple of muscle relaxers, but they both made me sleepy so I could not take during the day. Rheumatologist recommend taking an extra LYRICA pill lunchtime to help, but to no avail. I have been in constant pain since 4/12/18.
Patient receives home health, the home health nurse came to patient's home and gave the vaccine. By the next morning he had sore arm and minor weakness. The Sunday 1/31/2021 he was fine till that evening around 6PM he became confused and experienced memory loss. That lasted all evening until he went to bed. The morning when he woke up he seemed okay.
This spontaneous report was received from a Licensed Practical Nurse, referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On an unspecified date in March 2016, unspecified number of PROQUAD vaccines were exposed to a temperatures ranged from -1.0 degree C to -14.8 degrees C. After that, on unspecified dates in 2016, the patients were vaccinated with lot numbers: L007230 (expiration date: 03-SEP-2016), and L002213 (expiration date 21-JUL-2016). No adverse events were reported. The licensed practical nurse, stated that the vaccines were not previous exposed to temperature excursion. Information was recorded from a data logger. This is one of two reports received from the same source. Additional information has been requested.
Tingling on the left face (I previously had shingles in the same place),  Two days later I was tied and had whole-body ache.
Initial unsolicited report received from a consumer (parent) on 12 September 2015. This case involves a 14-year-old female patient, who was vaccinated with a dose Meningococcal vaccine [dose, dose in series, route and site of administration were not reported] on an unknown date. The patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient had meningitis, hearing loss, vision loss, tremors on her left side and lost 20 pounds. The patient was hospitalized for two weeks (on an unknown date). The patient was completely healthy at the age of 19 year. Laboratory data was not reported. Corrective treatment included azithromycin. On an unknown date, the patient was recovered from all the events. List of documents held by sender: none.